Brain Cancer Trial, Recruiting NCT07174661 Sponsor: Mayo Clinic Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT07174661
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who were between 18 and 39 years old when they were first diagnosed with cancer
  • People diagnosed with a stage III or IV solid tumour (a cancer that forms a solid mass), or a high-grade brain tumour, within the last 12 months — this also includes people whose cancer was previously stage I or II and has now returned at stage III or IV
  • People currently receiving their main cancer care at Mayo Clinic Arizona
  • People who are able to read, understand, and speak English
  • People who have already completed advance directive documents (written instructions about future medical care) are still eligible to participate
  • People who have access to the internet and a computer or smartphone

Who may not be able to join:

  • People who were younger than 18 or older than 39 at the time of their first cancer diagnosis
  • People diagnosed with a stage I or II solid tumour, a low-grade brain tumour, or a blood cancer (such as leukaemia or lymphoma)
  • People who are not receiving their main cancer care at Mayo Clinic Arizona
  • People who are not able to read, understand, and speak English
  • People whose original diagnosis or advanced-stage relapse was more than 12 months ago, including those currently in survivorship care or on hospice
  • People without access to the internet or a device such as a computer or smartphone

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Allison C. Rosenthal, DO, Mayo Clinic

Phone: 507-538-6811

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
2 September 2025
Est. completion
30 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of implementing routine, early Advance Care Planning (ACP); Satisfaction with each intervention component (Acceptability)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov